MYAM
ALNY icon

Meiji Yasuda Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Meiji Yasuda Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Buy
+1,085
New +$327K 0.01% 448
2025
Q2 		– Sell
-1,986
Closed -$536K – 546
2025
Q1 		$536K Hold
1,986
– – 0.02% 423
2024
Q4 		$467K Hold
1,986
– – 0.02% 450
2024
Q3 		$546K Sell
1,986
-44
-2% -$11.5K 0.02% 422
2024
Q2 		$493K Buy
2,030
+270
+15% +$42.6K 0.02% 430
2024
Q1 		$263K Buy
1,760
+380
+28% +$63.4K 0.01% 573
2023
Q4 		$264K Hold
1,380
– – 0.01% 485
2023
Q3 		$244K Buy
1,380
+160
+13% +$30.5K 0.01% 553
2023
Q2 		$232K Hold
1,220
– – 0.01% 557
2023
Q1 		$244K Buy
1,220
+50
+4% +$10.5K 0.01% 534
2022
Q4 		$278K Sell
1,170
-50
-4% -$10.7K 0.01% 525
2022
Q3 		$244K Sell
1,220
-190
-13% -$36.2K 0.01% 538
2022
Q2 		$206K Buy
1,410
+160
+13% +$22.7K 0.01% 600
2022
Q1 		$204K Sell
1,250
-150
-11% -$22.9K 0.01% 601
2021
Q4 		$237K Buy
1,400
+160
+13% +$29.7K 0.01% 501
2021
Q3 		$234K Buy
1,240
+60
+5% +$11.3K 0.02% 473
2021
Q2 		$200K Buy
+1,180
New +$173K 0.01% 510
2020
Q3 		– Sell
-1,470
Closed -$218K – 374
2020
Q2 		$218K Buy
+1,470
New +$198K 0.02% 444

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meiji Yasuda Asset Management's ALNY Position: Q2 2026 in Review

Meiji Yasuda Asset Management opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 1,085 shares worth $327K. The stake represents 0.01% of the portfolio and ranks #448 among its holdings. This is a return to the name: Meiji Yasuda Asset Management previously reported a position in ALNY as recently as Q1 2025.

Meiji Yasuda Asset Management first reported a position in ALNY in Q2 2020 and has held it in 18 quarters since. The position peaked at $546K in Q3 2024. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Meiji Yasuda Asset Management held 1,085 shares of Alnylam Pharmaceuticals worth $327K as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Meiji Yasuda Asset Management position in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #448 holding.
  • Meiji Yasuda Asset Management first reported a position in Alnylam Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • Meiji Yasuda Asset Management's Alnylam Pharmaceuticals position peaked at $546K in Q3 2024.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.